Axsome Therapeutics
AXSM
AXSM
225 hedge funds and large institutions have $2.65B invested in Axsome Therapeutics in 2023 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 87 increasing their positions, 71 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
1% more capital invested
Capital invested by funds: $2.61B → $2.65B (+$33.4M)
7% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 28
2% less funds holding
Funds holding: 230 → 225 (-5)
Holders
225
Holding in Top 10
10
Calls
$56.4M
Puts
$36.8M
Top Buyers
| 1 | +$58.8M | |
| 2 | +$52.9M | |
| 3 | +$38.7M | |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$24.2M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$14.9M |
Top Sellers
| 1 | -$24.4M | |
| 2 | -$18.9M | |
| 3 | -$17.3M | |
| 4 |
Millennium Management
New York
|
-$16.2M |
| 5 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
-$11.7M |